Skip to NavigationSkip to content

News

0
Theramex has recently launched the first and only body-identical hormone therapy treatment (HRT) for post-menopausal women, in the form of Bijuva/...
0
Eurazeo has announced its intention to raise its stake in Kurma Partners, a French venture capital firm specialising in biotechnology and medical...
0
The PROpel Phase III trial has shown that Lynparza (olaparib) in combination with abiraterone demonstrated a significant improvement in radiographic...
0
The FDA have approved a booster dose of the Pfizer BioNTech COVID-19 vaccine for those aged 65 and above, as well as for immunocompromised people...

Features

The market for medical cannabis has been growing steadily over the last decade, but it may be on the cusp of a breakthrough in oncology. Kat...